Reference values for the external genitalia of full-term and pre-term female neonates.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 16 12 2019
revised: 15 05 2020
accepted: 24 05 2020
pubmed: 21 6 2020
medline: 5 1 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

Identifying virilisation of the genitalia in female newborns early during the neonatal period is important to diagnose pathologies. However, there is no clear threshold for clitoromegaly or for the anogenital ratio. The objective of this study was to define reference values for the external genitalia of full-term and pre-term female neonates. This was a prospective study of all females born in the study centre between May 2014 and July 2016. Clitoral length and anogenital ratio were measured in 619 newborns with a gestational age of 24+2 to 41+3 weeks during their first 3 days of life. Associations between the values at day 3 and gestational age, birth weight and other newborn characteristics were examined by linear regression. The mean clitoral length at day 3 of life was 3.69±1.53 mm (n=551; 95th percentile, 6.5 mm; maximum, 8 mm), and the mean anogenital ratio was 0.42±0.09 (95th percentile, 0.58). There was no significant variation with gestational age or birth weight, and no significant difference between the results at day 0 and day 3. These results suggest that clitoromegaly can be defined as a clitoral length >6.5 mm. Values ≥8 mm should prompt further investigations. An anogenital ratio >0.6 should be considered a sign of virilisation. Since clitoral size does not vary with gestational age or birth weight, clitoromegaly should not be attributed to prematurity.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Identifying virilisation of the genitalia in female newborns early during the neonatal period is important to diagnose pathologies. However, there is no clear threshold for clitoromegaly or for the anogenital ratio. The objective of this study was to define reference values for the external genitalia of full-term and pre-term female neonates.
DESIGN METHODS
This was a prospective study of all females born in the study centre between May 2014 and July 2016. Clitoral length and anogenital ratio were measured in 619 newborns with a gestational age of 24+2 to 41+3 weeks during their first 3 days of life. Associations between the values at day 3 and gestational age, birth weight and other newborn characteristics were examined by linear regression.
RESULTS RESULTS
The mean clitoral length at day 3 of life was 3.69±1.53 mm (n=551; 95th percentile, 6.5 mm; maximum, 8 mm), and the mean anogenital ratio was 0.42±0.09 (95th percentile, 0.58). There was no significant variation with gestational age or birth weight, and no significant difference between the results at day 0 and day 3.
CONCLUSION CONCLUSIONS
These results suggest that clitoromegaly can be defined as a clitoral length >6.5 mm. Values ≥8 mm should prompt further investigations. An anogenital ratio >0.6 should be considered a sign of virilisation. Since clitoral size does not vary with gestational age or birth weight, clitoromegaly should not be attributed to prematurity.

Identifiants

pubmed: 32561564
pii: archdischild-2019-318090
doi: 10.1136/archdischild-2019-318090
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-44

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sarah Castets (S)

Service d'endocrinologie pédiatrique, Hospices Civils de Lyon, Lyon, France sarah.castets@ap-hm.fr.
Pédiatrie multidisciplinaire, Assistance Publique Hopitaux de Marseille, Marseille, France.

Kim-An Nguyen (KA)

Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

Franck Plaisant (F)

Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

Malika Baya Prudon (MB)

Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

Ingrid Plotton (I)

Laboratoire de biochimie et de biologie moléculaire, Hospices Civils de Lyon Centre de pathologie et biologie Est, Bron, France.

Behrouz Kassai (B)

Service de pharmacologie clinique, Hospices Civils de Lyon, Lyon, France.
Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique Santé, CNRS UMR 5558, Universite de Lyon, Lyon, France.

Sylvain Roche (S)

Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

Rene Ecochard (R)

Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Olivier Claris (O)

Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

Marc Nicolino (M)

Service d'endocrinologie pédiatrique, Hospices Civils de Lyon, Lyon, France.
INSERM U870, Université de Lyon, Lyon, France.
Centre de référence du développement génital, du fœtus à l'adulte, Hospices Civils de Lyon, Lyon, France.

Carine Villanueva (C)

Service d'endocrinologie pédiatrique, Hospices Civils de Lyon, Lyon, France.

Claire-Lise Gay (CL)

Service d'endocrinologie pédiatrique, Hospices Civils de Lyon, Lyon, France.
Centre de référence du développement génital, du fœtus à l'adulte, Hospices Civils de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH